Buprenorphine-Induced Changes in Mu-Opioid Receptor Availability in Male Heroin-Dependent Volunteers: A Preliminary Study | Neuropsychopharmacology
Frontiers | Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink
Comprehensive molecular pharmacology screening reveals potential new receptor interactions for clinically relevant opioids | PLOS ONE
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Mu Agonist Opioids and Kappa Opioids | Download Table
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects | Journal of Medicinal Chemistry
Perioperative Management of Opioid Use Disorder Patients on Buprenorphine/ Naloxone : WFSA - Resources
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
Receptor Occupancy Assay | Melior Discovery
Buprenorphine for Opioid Use Disorder: Mechanism of Action - Psychopharmacology Institute
Optimization of a Series of Mu Opioid Receptor (MOR) Agonists with High G Protein Signaling Bias | Journal of Medicinal Chemistry
Buprenorphine: A Promising Yet Overlooked Tool
Buprenorphine: A Promising Yet Overlooked Tool
Buprenorphine -binding affinity (Ki, nM) for opioid receptors | Download Table
Dose-dependent in vivo receptor occupancy at putative mu, kappa, | Download Scientific Diagram
Buprenorphine/Naloxone Toxicity: Practice Essentials, Background, Pathophysiology
Opioid Use Disorder Medications - Pharmacokinetics Buprenorphine ... | GrepMed
Opioids to Treat Depression: The Jury Is Out
Clinical Aspects of Buprenorphine Therapy in the HIV Primary Care Set…
Opioid Receptors Mnemonic | Epomedicine
Application of Receptor Theory to the Design and Use of Fixed-Proportion Mu-Opioid Agonist and Antagonist Mixtures in Rhesus Monkeys | Journal of Pharmacology and Experimental Therapeutics
Buprenorphine/Naloxone Toxicity: Practice Essentials, Background, Pathophysiology
